Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-02-24 @ 2:31 PM
Study NCT ID:
NCT00109993
Status:
COMPLETED
Last Update Posted:
2010-06-11
First Post:
2005-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Campath-1H + FK506 and Methylprednisolone for GVHD
Sponsor:
Case Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE1Z04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mary Laughlin, MD
Old Organization:
Ireland Cancer Center at University Hospitals Case Medical Center,Case Comprehensive Cancer Center
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |